Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$6.5 - $12.85 $6,500 - $12,850
1,000 New
1,000 $7,000
Q1 2023

May 01, 2023

SELL
$7.32 - $14.38 $63,684 - $125,106
-8,700 Reduced 96.67%
300 $0
Q4 2022

Feb 07, 2023

SELL
$7.19 - $13.16 $75,495 - $138,180
-10,500 Reduced 53.85%
9,000 $0
Q3 2022

Oct 25, 2022

BUY
$0.0 - $12.8 $0 - $136,960
10,700 Added 121.59%
19,500 $14,000
Q2 2022

Aug 04, 2022

BUY
$5.28 - $18.9 $46,464 - $166,320
8,800 New
8,800 $3,000
Q3 2021

Oct 26, 2021

SELL
$41.3 - $54.56 $119,769 - $158,224
-2,900 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$38.61 - $55.0 $77,220 - $110,000
2,000 Added 222.22%
2,900 $6,000
Q1 2021

Apr 26, 2021

BUY
$38.1 - $59.09 $3,810 - $5,909
100 Added 12.5%
900 $2,000
Q4 2020

Jan 21, 2021

BUY
$33.26 - $59.72 $26,608 - $47,776
800 New
800 $1,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $278M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.